Foghorn Therapeutics Inc. Comparables
Find the most relevant public market comparables for Foghorn Therapeutics Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company focused on discovering and developing a new class of medicines that target genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform provides a mechanistic understanding of how components of this system interact, enabling the identification and validation of potential drug targets. The company is developing therapies for various cancers, including hematologic cancers and solid tumors.
Business Model
Discovery and development of novel oncology medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify and validate drug targets.
Target Customers
Patients with various cancers, including hematologic cancers and solid tumors.
Specific Focus
Precision oncology therapeutics targeting the chromatin regulatory system
Location
Cambridge, Massachusetts
CEO
Adrian Gottschalk
Industry
Life sciences
Sub Sector
Oncology
3yr Revenue Growth
7,843%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Foghorn Therapeutics Inc. in the Biotechnology sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Foghorn Therapeutics Inc.? Our platform provides detailed analysis of Foghorn Therapeutics Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Foghorn Therapeutics Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Foghorn Therapeutics Inc. Compset
As a leading player in the Life sciences industry within the Biotechnology sector, Foghorn Therapeutics Inc. operates in the specialized Oncology sub-sector. Understanding how Foghorn Therapeutics Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Oncology space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
TG Therapeutics, Inc.
Healthcare • Life sciences
TG Therapeutics, Inc. is a fully integrated, commercial-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. They have received FDA approval for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis.
Vytalize Health
Healthcare • Life sciences
Vytalize Health is a risk-bearing provider enablement platform and leading Accountable Care Organization (ACO) that partners with primary care physicians (PCPs) to deliver value-based care, improving patient outcomes and reducing healthcare costs. They offer an all-in-one solution including value-based incentives, smart technology, and a virtual clinic, enabling independent practices to thrive in value-based care arrangements. The company focuses on Medicare patients and works with over 2,500 PCPs across 36 states.
Talkiatry
Healthcare • Life sciences
Talkiatry is a national mental health practice providing in-network psychiatry and therapy via telehealth. It utilizes technology and a human-centered approach to improve access to high-quality mental healthcare, addressing issues of accessibility and affordability.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Foghorn Therapeutics Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free